Management and outcomes of vaginal bleeding and heavy menstrual bleeding in women of reproductive age on direct oral anti-factor Xa inhibitor therapy: a case series-Reference-Cited by-同舟云学术

Management and outcomes of vaginal bleeding and heavy menstrual bleeding in women of reproductive age on direct oral anti-factor Xa inhibitor therapy: a case series

Published:2016-10 Issue:10 Volume:3 Page:e480-e488
ISSN:2352-3026
Container-title:The Lancet Haematology
language:en
Short-container-title:The Lancet Haematology

Author:

Beyer-Westendorf Jan,Michalski Franziska,Tittl Luise,Hauswald-Dörschel Susann,Marten Sandra

Publisher

Elsevier BV

Subject

Hematology

Reference23 articles.

1. Risk of major bleeding in different indications for new oral anticoagulants: insights from a meta-analysis of approved dosages from 50 randomized trials;Sardar;Int J Cardiol,2015

2. Menstrual problems and contraception in women of reproductive age receiving oral anticoagulation;Huq;Contraception,2011

3. Heavy menstrual bleeding on rivaroxaban;Ferreira;Br J Haematol,2016

4. Abnormal uterine bleeding in VTE patients treated with rivaroxaban compared to vitamin K antagonists;De Crem;Thromb Res,2015

5. Recurrent venous thromboembolism and abnormal uterine bleeding with anticoagulant and hormone therapy use;Martinelli;Blood,2016

Cited by 54 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Life-threatening vaginal bleeding after starting rivaroxaban treatment;Ugeskrift for Læger;2024-05-27

2. Abnormal uterine bleeding in anticoagulated patients by drug class: outcomes and management;American Journal of Obstetrics and Gynecology;2023-09

3. Thrombose und hormonale Kontrazeption;Die Gynäkologie;2023-08-15

4. How do anticoagulants impact menstrual bleeding and quality of life? - The PERIOD study;Research and Practice in Thrombosis and Haemostasis;2023-02

5. Gender-Associated Variation in DOAC Levels;Clinical Laboratory;2023